Tech Transfer eNews Blog
Industry-Sponsored Research Management sample issue

Deerfield and Vanderbilt partner to accelerate new therapeutics

By Jesse Schwartz
Published: April 4th, 2018

Healthcare investment firm Deerfield Management and Vanderbilt University have launched a new company to support innovative life science research at the university.

Ancora Innovation will leverage Deerfield’s expertise in accelerating drug development and offer funding to Vanderbilt research projects with the goal of changing the current paradigm of drug development and creating novel therapeutics to cure life-altering diseases.

Deerfield will commit up to $65 million to this mission. The goal is to carry research further than is typical of university labs, de-risking and enhancing the value of technologies and start-ups. Profits from the fund will be donated to the Deerfield Foundation, which will in turn fund projects that lack a commercial market but are crucial to medical innovation. It’s just the latest big-ticket investment in university research from Deerfield, which has inked similar arrangements with the Broad Institute of MIT and Harvard as well as with Johns Hopkins University.

“It is an honor to be collaborating with Vanderbilt, a world-renowned university with superior science and a true focus on research,” says James Flynn, managing partner at Deerfield. “The ability to speed Vanderbilt discoveries to market while enhancing our ability to support not-for-profit research through the Deerfield Foundation makes this collaboration important and meaningful.”

Padma Raghavan, vice provost for research at Vanderbilt University, comments, “This collaboration enhances Vanderbilt’s core mission of improving the quality of human life through research. Deerfield is aligned with us in accomplishing this mission, and we look forward to working with them to develop new life-changing and lifesaving therapies.”

Source: Vanderbilt University

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment